Neal Azrolan

Hypertriglyceridemia as a Result of Human apo <i>CII</i> Gene Expression in Transgenic Mice

Yasushi Ito, Neal Azrolan, Anita M. O'Connell et al. · Science · 1990 · 541 citations

Genetics, Genetic Epidemiology, Pathology +22

Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme

Kelem Kassahun, Ian McIntosh, Donghui Cui et al. · Drug Metabolism and Disposition · 2007 · 274 citations

Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

Dov Gavish, Neal Azrolan, J L Breslow · Journal of Clinical Investigation · 1989 · 156 citations · Full text

Vascular Disease, Genetics, Molecular Biology +20

Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.

Tony Hayek, Yasushi Ito, Neal Azrolan et al. · Journal of Clinical Investigation · 1993 · 143 citations · Full text

Hdl Cholesterol Ester, Nutrition, Metabolic Syndrome +15

Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.

Tony Hayek, Neal Azrolan, Roy B. Verdery et al. · Journal of Clinical Investigation · 1993 · 131 citations · Full text

Metabolic Syndrome, Hdl Ce Tr, Lipid Synthesis +15